Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108484499B reveals a green rhodium-catalyzed route to isoquinolines using hydroxylamine and alkynes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113511986B reveals catalyst-free aryl acetonitrile synthesis. Offers green manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free route for 3,4,5-trisubstituted 1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115246786B details a palladium-catalyzed carbonylation method for indole and benzoxazine compounds, offering scalable routes and cost advantages for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN116640097B reveals metal-free sulfur-mediated cyclization for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate tolerance for pharmaceutical manufacturing.
Novel synthesis method offers high enantioselectivity and mild conditions for pharmaceutical intermediates manufacturing supply chain cost reduction and reliability improvements.
Patent CN114409714B reveals a palladium-catalyzed route for planar chiral ferrocenes. This method offers high enantioselectivity and scalable manufacturing for global supply chains.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for scalable production of bioactive heterocycles.
Patent CN112778317B reveals a novel metal-free one-pot synthesis for [1,2,4]triazolo[1,5-a]pyrimidines, offering significant cost reduction and high purity for API manufacturing.
Patent CN107973779A reveals mild Pd-catalyzed cyclization for indole derivatives. Enables cost reduction and scalable supply chain for pharmaceutical intermediate manufacturing globally.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for scalable production of bioactive heterocycles.
Novel protonic acid catalysis reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN120172978B details a mild trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and scalable supply chain solutions.
Novel patent CN121378226A reveals mild synthesis for oxindole compounds. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Novel one-pot Suzuki coupling method for Darolutamide intermediate. Eliminates column chromatography, reduces cost, ensures supply continuity for pharmaceutical manufacturing.
Patent CN102382051A reveals efficient copper-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain solutions.